EORTC protocol 05011

Time finding study of chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer.
Trial StatusAll trial activities ended
DatesDate of activation: 07-Feb-02
Closed on : 05-Aug-05
Data management at EORTCFull
Phase1
Randomized trialYes
TypeAdvanced
Targeted Sample size186
Number of steps1
DrugFluorouracil
Leucovorin
Irinotecan
Oxaliplatin
Study StaffCarlo Garufi (Study Coordinator) - Istituto Regina Elena, Roma
Thierry Gorlia (Statistician) - EORTC Headquarters, Brussels
Marie-Ange Lentz (Data Manager) - EORTC Headquarters, Brussels
Sandrine Marreaud (Coordinating Physician) - EORTC Headquarters, Brussels
Type of cancerColon
Rectal
Participating GroupsEORTC Chronotherapy Group (closed group)(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00039208
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
Back to Protocol section